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E-mail address: bchtbl@nus.edu.sg (B.L. Tang).The Rab family of GTPases are regulators of eukaryotic vesicular membrane trafﬁc, while modula-
tion of actin dynamics is a function conventionally associated with the Rho family of GTPases.
Rab35 is a Rab protein with both plasma membrane and endosomal localization, and has been
implicated in diverse processes that include T-cell receptor recycling, oocyte yolk protein recycling
and cytokinesis. Rab35 regulates neurite outgrowth in neuronal-like cells, and can induce protru-
sions even in typically non-adherent Jurkat T-cells. Recent evidence indicates that Rab35’s activity,
particularly the ability to mediate protrusive outgrowths, is due to its direct inﬂuence on actin
dynamics. This can occur via activation of the Rho family of GTPases, or through the engagement
of its effector fascin, an actin bundling protein.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Rab GTPases are members of the Ras superfamily of small
GTPases [1], and collectively function in regulating the myriad of
membrane transport processes in eukaryotic cells [2,3]. In its
GTP-bound and active form, Rabs mediate vesicular trafﬁc via the
recruitment of effector molecules such as tethering complexes
[4] and motor proteins [5]. As per other small GTPases of the Ras
superfamily, Rab activities are principally regulated by a family
of guanine nucleotide exchange factors (GEFs), which catalyze
GTP loading, and GTPase activating proteins (GAPs), which stimu-
late the intrinsically low GTPase activities of Rabs to effectively
convert them into GDP-bound, inactive forms [6]. Rab’s function
in membrane trafﬁc is dependent on cycles of reversible
membrane attachment and dissociation [7,8]. Rab geranylgeranyl-
transferase, in concert with Rab escort protein (REP), provide Rabs
with a prenylation anchor for membrane attachment. Rab guanine
nucleotide dissociation inhibitor (Rab GDI), retrieves GDP-bound
Rab from the membrane after GTP hydrolysis.
The Rab proteins (numbering more than 70) and their effectors
collectively coordinate consecutive stages of transport, including
vesicle generation from donor membranes, vectorial motility of
vesicles or cargo carriers, and tethering of vesicles/carriers to tar-
get membranes. Rabs have been conceptualized as membrane
organizers in terms of membrane transport activities [9], withchemical Societies. Published by Efunctional boundaries demarcated by sequential and combined ac-
tion of GEFs and GAPs [10,11]. As cell adhesion and cell migration
are both processes that require vectorial trafﬁcking of protein com-
ponents to speciﬁc plasma membrane sites, a crosstalk between
Rab family-mediated transport processes and Rho family-mediated
changes in actin dynamics (another component of adhesion and
migration) have long been recognized.
Rab35 was ﬁrst identiﬁed and cloned from a human skeletal
muscle cDNA library in 1994 [12]. Amongst Rabs, it bears the clos-
est homologies with yeast Ypt1p and mammalian Rab1a and
Rab1b, diverging at the C-terminal portion, and was given names
like Rab1c and H-Ray (or Ray). It was subsequently annotated by
authors performing comparative genome analysis for genes encod-
ing the eukaryotic membrane trafﬁc machinery [13,14] as Rab35.
Rab35 transcripts are apparently ubiquitously expressed, and at
fairly similar levels in major human tissues analyzed [12]. The gene
is also well-conserved evolutionarily, with clear homologues pres-
ent in invertebrates and lower organisms. These would specula-
tively suggest that Rab35 has general and important cellular and/
or developmental functions.
Some of the earliest functional study of Rab35 revealed results
that appeared not to be directly related to its cognate role in
membrane trafﬁcking, but rather showed that it is an interacting
partner for nucleophosmin-anaplastic lymphoma kinase (NPM-
ALK) [15] and p53-related protein kinase (PRPK) [16]. In the case
of the latter interaction, active forms of Rab35/Ray could redistrib-
ute PRPK to the cytosol and suppress PRPK-induced p53 transcrip-
tional activity. Further mechanistic underpinnings of theselsevier B.V. All rights reserved.
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Rab35 is involved in oncogenic or tumor suppressive activities of
these putative interacting partners.
Subsequent analysis in different systems has revealed an amaz-
ingly diverse array of Rab35 associations and functions. Acting in
the context of endosomal trafﬁcking and recycling, Rab35 has been
shown to regulate cytokinesis of Drosophila S2 cells and HeLa cells
[17], oocyte receptor recycling in Caenorhabditis elegans [18], and
T-cell receptor recycling [19]. Furthermore, Rab35 stimulates neu-
rite outgrowth in PC12 and N1E-115 cells [20], apparently via
interaction with Rho family GTPases and modulation of actin
dynamics. Very recently, Rab35’s involvement in Drosophila bristle
formation is recognized, and this led to the identiﬁcation of fascin,
an actin bundling protein as a Rab35 effector by Scott and cowork-
ers [21]. The emerging roles of this ubiquitous Rab protein in mul-
tiple systems and its unconventional, direct modulation of actin
are discussed further below.2. Rab35’s role in plasma membrane recycling and cytokinesis
In spite of Rab35’s distinctive homology to Rab1a and Rab1b,
which function in ER-Golgi transport, initial demonstrations of
Rab35’s subcellular localization [16,17] suggest that it could be
functionally distinct from its two other paralogues. Over-expressed
tagged Rab35 in various cell types could be found at the plasma
membrane, cytosol and the nucleus, with the latter localization
apparently dependent on a polybasic sequence at the C-terminus
[16,19–21]. Endogenous Rab35 in HeLa cells are found mainly at
the plasma membrane, and the cytosol, with labeling of intracellu-
lar endosomal structures identiﬁable at the ultrastructural level
[17]. Rab35’s lack of ER-Golgi localization is therefore not consis-
tent with a possible function at the early exocytic pathway, but
rather suggests an endocytic, or endosome-plasma membrane
recycling activity.
An endosome-plasma membrane recycling activity was indeed
the ﬁrst membrane trafﬁcking function associated with Rab35. In
screening for Drosophila Rabs that are important for cytokinesis
using Drosophila S2 cells, Echard and coworkers [17] identiﬁed
Rab35 as the one that produces the strongest cytokinesis defect
phenotype (binucleate cells). Investigations in HeLa cells revealed
a conserved phenotype, where Rab35 silencing or dominant-nega-
tive mutant destabilizes the intercellular bridges that formed after
cleavage furrow ingression, and the accumulation of cytoplasmic
vacuoles. Kinetics measurement of transferrin transport indicated
that the Rab35 loss-of-function manipulations affected not endo-
cytic internalization, but a fast recycling pathway back to the plas-
ma membrane. Cytokinesis involves extensive localized membrane
distortion and remodeling at the plasma membrane of the cleavage
site, and requires polarized, targeted delivery of speciﬁc lipids and
proteins [22,23]. Rab35’s functional inhibition resulted in signiﬁ-
cant reduction of enrichment of a lipid, phosphatidylinositol 4,5-
bisphosphate (PIP2), and a protein component, septin, that are
important for successful cytokinesis at the intercellular bridge
membranes. Rab35 may therefore perform a function analogous
to that of Rab11 and its effectors in this regard [24]. These two
Rabs may speculatively share some regulators and effectors that
mediate polarized membrane trafﬁc to cleavage sites, but their
activities and functions in cytokinesis could be non-identical and
non-redundant.3. Rab35’s role in receptor recycling
More recent works have provided further emphatic evidence for
Rab35’s role in endocytic recycling in diverse systems. Shaw and
colleagues [19] found that Rab35 and a GAP molecule, EBP50-PDZ interactor of 64k C (EPI64C), that is enriched in the hematopoi-
etic system, functions in T-cell receptor recycling. Over-expression
of EPI64C induced the formation of vacuoles enriched in transferrin
receptor, T cell receptor-f (TCR-f) and SNAREs involved in T-cell
receptor exocytosis in Jurkat cells. A screen for Rabs that also be-
came enriched on these vacuoles identiﬁed Rab35. The authors
showed that EPI64C could indeed be a GAP for Rab35, as it pro-
motes the GTPase activity of Rab35 in vitro, and a dominant-nega-
tive mutant of the latter induced vacuole formation, paralleling the
effect of EPI64C over-expression. Conversely, a constitutively ac-
tive mutant suppressed vacuole formation.
Adaptive immune response comes about through the activation
of T and B cells by antigen-presenting cells, through a specialized
conjugation junction of intercellular communication that is analo-
gous to neuronal synapses, known as the immunological synapse
(IS) [25]. Using a cell culture model of IS formation between Jurkat
and Raji cells presenting the antigen staphylococcous enterotoxin
E, the authors showed that Rab35 became enriched in the junc-
tional contacts between Jurkat and Raji, colocalizing extensively
with accumulating TCR-f in a temporally concordant manner.
Over-expression of EPI64C and dominant-negative forms of
Rab35 blocks Jurkat–Raji conjugate formation. It appears that
Rab35 has a pivotal role in the T-cell speciﬁc function of conjuga-
tion with antigen-presenting cells, and acts by regulating the
movement of TCR and perhaps other TCR associated factors, to
the IS.
Another link between Rab35 and immune function has also
been recently reported. In HeLa cells expressing Major Histocom-
patibility Complex (MHC) class II molecules, internalized pep-
tide-loaded MHC-II molecules are localized to tubular endosomes
that are positive for both Arf6 and Rab35. Rab35S22N expression
disrupted the normal tubular endosome morphology, and relocal-
ized internalized peptide-MHC-II onto vesicular structures [26].
Again, this shows the importance of Rab35 in the localization of
receptors.
Demonstration of a role for Rab35 in receptor recycling also
came from a completely different system, that of C. elegans oocyte
yolk protein receptor recycling. Grant and colleagues characterized
two complementation groups of mutants with similar phenotype
identiﬁed based on a screen for defective yolk protein endocytosis
and trafﬁcking, receptor-mediated endocytosis rme-4 and rme-5
[18]. In both mutants, the levels of yolk protein receptor RME-2,
normally distributed at the plasma membrane and in vesicles
and tubular structures of the early and recycling endosomes, is sig-
niﬁcantly reduced from the cortical endosomes, but accumulate in
small dispersed vesicles. Both mutations therefore appear to affect
yolk protein receptor recycling. RME-5 is the worm Rab35 ortho-
logue, while RME-4 is a differentially expressed in neoplastic ver-
sus normal cells (DENN) domain [27] containing protein that is
localized to clathrin coated pits and could interact with the endo-
cytic adapter complex AP2. Both rme-4 and rme-5 mutations
strongly enhanced the recycling defects observed with RNAi of
rab11, indicating that these genes function in parallel rather than
along the same recycling pathway mediated by Rab11.
Interestingly, human DENN, also called the MAP kinase activat-
ing protein containing death domain (MADD) is a human ortho-
logue of rat Rab3 GEF and C. elegans AEX-3 (also a Rab27a GEF)
[28]. A Rab6 interacting protein, Rab6IP1 (which also interacts
with Rab11), also harbors a DENN domain [29]. This suggests that
the DENN domain-containing proteins interact with Rabs, possibly
in the role of GEFs. RME-4 indeed interacts with RME-5/Rab35, as
assessed by a yeast two-hybrid assay, and rather speciﬁcally to the
GDP-binding mutant form (S24N) and not the wild-type of GTPase
deﬁcient Q69L mutant, as might be expected of GEFs. This interac-
tion appears to regulate the association of Rab35 with cortical
endosomes.
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modulation of the actin cytoskeleton
A morphological observation arising from the work with Jurkat
cells is that Rab35 over-expression induced the formation of
peripheral protrusions in the otherwise ﬂatly spherical surface.
This occurs even in the absence of a conjugating partner. This indi-
cates that Rab35 activity may directly impinge on actin dynamics
in ways reminiscent of morphological changes when Rho family
members are over-expressed in cells [30]. Presley and coworkers
tested this notion directly [20]. Using baby hamster kidney (BHK)
cells, the authors observed that Rab35 colocalized extensively with
actin and, to a certain degree, with the Rho family members Rac1
and Cdc42. Over-expression of wild-type and constitutively active
GTP-bound mutant Rab35Q67L induced formation of long cell
extensions, while the GDP-locked Rab35S22N mutant reduced
the number of cell extensions. Active Rab35 also induced neurite
outgrowth in N1E-115 and PC12 cells, and basal levels of neurite
extension is attenuated by Rab35S22N and Rab35 silencing by
siRNA.
Interestingly, negative dominant forms of Rac1 and Cdc42
attenuated the formation of cell extensions by Rab35, strongly sug-
gesting a link between them. That there is extensive crosstalk be-
tween Rab35 and the Rho family GTPases is also evidenced by the
ability of Rab35 and Rab35Q67L to activate (i.e. increase GTP bind-
ing of) Cdc42 in vitro. Another point to note is that Rab35S22N
could moderately activate Cdc42. Rac1 is, however, not similarly
activated in this manner. These results indicate that Rab35 activity
could be linked to upstream regulators of Cdc42, such as Diffuse B-
cell lymphoma (Dbl) and dedicator of cytokinesis (DOCK) family
proteins, which catalyze the dissociation of GDP from small G pro-
teins of the Rho family.
Another recent report indicated that besides the abovemen-
tioned role of Rab35 in mediating neurite extension through inter-
actions with Rho family GTPases, Rab35 could modulate actin
dynamics in a more direct manner. In a systematic screen for Dro-
sophila Rabs’ abilities to inﬂuence ﬂy development using cell type
speciﬁc expression of their negative dominant GDP-bound mu-
tants, Scott and colleagues indentiﬁed the Drosophila Rab35 ortho-
logue as a modulator of actin [21]. Expression of negative
dominant mutant of Rab35 in peripheral nervous systems resulted
in abnormal bristle morphology with loose and disconnected actin
organization that is phenocopied by the Rab35 silencing with the
expression of a Rab35 small hairpin (sh) RNA. Ubiquitous expres-
sion of negative dominant Rab35 causes embryonic lethality, and
death of cells in culture, as would be expected of a protein which
has direct links with such a ubiquitous component of cell architec-
ture and function like actin.
Expression of wild-type Rab35 in Drosophila S2 cells induced ﬁl-
opodia-like cellular extensions, which is blocked by the actin poly-
merization inhibitor latrunculin A. The authors used a GTPcS-
loaded Rab35 pull-down of bovine brain lysates, followed by mass
spectrometry analysis, to identify fascin as a Rab35 effector. Fascin
is a small, globular actin bundling protein that functions in diverse
cell protrusion and in cytoplasmic actin bundles [31]. It is widely
expressed, particularly abundant in the nervous system, and has
been extensively implicated in cancer cell migration [32,33]. That
fascin mediates at least part of Rab35 function is evidenced by
the fact that transgenic over-expression of fascin in peripheral neu-
rons suppressed the bristle phenotype caused by Rab35 silencing.
A fascin mutant that could not be inactivated by phosphorylation
of Ser39 (S39A) enhanced Rab35-induced ﬁlopodia formation. On
the other hand, fascin silencing by shRNA, and overexpression of
an inactive phosphorylation mimic mutant (S39D) reduced the
number of Rab35-induced ﬁlopodia. Ectopic targeting of Rab35 tothe mitochondrial membrane resulted in the mitochondria being
abnormally decorated with an actin meshwork, and the recruit-
ment of fascin to these sites. Thus, active Rab35 could directly
stimulate local actin dynamics through the engagement of an
effector which is an actin bundling protein.
5. Rab35: pathways, regulators and effectors
From the recent ﬁndings on Rab35 functions highlighted above,
several general implications are outstanding. Firstly, Rab35’s
importance is evolutionarily conserved from mammals to lower
invertebrates. Our appreciation of the role of Rab35 in mammalian
embryonic development, however, awaits targeted deletion analy-
sis. Secondly, its activity appears to serve multiple organs and cel-
lular systems where endocytic recycling is important, but
functions in a pathway that is parallel to, rather than part of that
mediated by Rab11. The exact subcellular trafﬁcking pathway(s)
in which Rab35 is involved in has yet to be exhaustively deﬁned.
Accumulating evidence suggests that it is likely to function in a
route from the endosomal recycling compartment, or recycling
endosomes (RE), to the plasma membrane. Recycling of internal-
ized membrane materials to the plasma membrane can occur di-
rectly from peripheral early endosomes. Many cells, however,
also harbor a subpopulation of endosomes which are more perin-
uclearly localized, has a heterogeneous tubular-vesicular morphol-
ogy, a slightly higher pH, and appear to dynamically recycle
membrane components [34]. The most prominent Rabs associated
with the RE is the Rab11 subfamily of Rab11a, Rab11b and Rab25.
Acting through a family of effectors known as Rab11-Family Inter-
acting Proteins (Rab11-FIPs) [35], Rab11 has been extensively
implicated in endosomal recycling, particularly polarized cell types
like epithelial cells [36,37] and neurons [38].
The membrane staining pattern of Rab35 and Rab11 in inter-
phase cells seems to have a large degree of overlap. It also appears
that Rab35 and Rab11’s gross membrane trafﬁc functions overlap
signiﬁcantly, and manipulation of their activities affects common
recycling cargoes such as the transferrin receptor. Rab11 has also
been shown to play a role in the delivery of membrane to the
cleavage furrow/midbody region, and its essential functional role
in cytokinesis of a range of model organisms has been ﬁrmly estab-
lished [39,40]. The Drosophila Rab11 effector Nuclear fallout (Nuf)
mediates actin remodeling during cytokinesis, likely through the
engagement of Rho-GEF2-Rho1 [41]. Rab11 could also regulate
neurite outgrowth through its interaction with molecules like pro-
trudin [42] and the exocyst complex [43], both of which promote
neurite outgrowth. Members of the Rab11 subfamily regulates cal-
cium induced exocytosis [44] and Rab11 is critical for embryonic
nervous system development in Drosophila [45]. It also plays a role
in the targeting of Lymphocyte-speciﬁc protein tyrosine kinase
(Lck) from the RE to immune synapses [46].
What exactly is the role of Rab35 in RE-cell surface transport
and how does this intersect with that of Rab11? One scenario is,
in some cell types at least, Rab11 and Rab35 function sequentially
in RE to plasma membrane transport. However, in the cases of
cytokinesis and C. elegans yolk receptor recycling discussed above,
Rab35 likely regulates a recycling pathway that is parallel and dis-
tinct from that organized by Rab11. These two pathways, as spec-
ulatively depicted in Fig. 1, could still be linked by divalent Rab
effectors as in the case of early endosomal Rab4 and Rab5 [47].
On the other hand, transport carriers from the RE could carry both
Rab11 and Rab35 in proportions determined by the types of mem-
brane cargo in a cell type speciﬁc, or cell physiology dependent
manner. These Rabs may engage different effectors, and the func-
tional efﬁciency of the carriers in response to the depletion of
Rab11 and Rab35 would vary. Thus far, only a putative GAP,
Fig. 1. A schematic diagram illustrating the pathways and Rabs involved the exocytic/endocytic boundary in a generalized cell. Modes of transport from RE to the cell surface
may involve pathways separately regulated by Rab11 or Rab35 (a or b), or one in which Rab11 and Rab35 functions sequentially (c). Another layer of complexity is that
transport carriers from RE to the plasma membrane may carry exclusively Rab11 or Rab35 and their respective effectors (I or II), or both Rabs could be present in differing
stoichiometry depending on the cell type and physiological states of the cell (III).
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or any of its mammalian homologues could serve as a GEF for
Rab35 is unclear. Rab35 may also share some effectors with
Rab11, of which the Rab11-FIPs and the exocyst should need to
be quickly veriﬁed. Deﬁning the pathways and factors (both over-
lapping and exclusive ones) involved in Rab11 and Rab35 function
in different systems of endocytic recycling would clearly be of
immediate interest.
The third general implication of the studies highlighted in the
previous sections is that Rab35 activity could also extend to other
cellular processes not directly linked to endocytic recycling. One of
these might be related to its apparent presence in the nucleus and
its interaction with PRPK. Another of Rab35’s roles is in its involve-
ment in the modulation of actin dynamics, either through activa-
tion of Rho family GTPases, or through the engagement of fascin.
This is perhaps one of the more unusual roles of Rab35, as actin
dynamics are largely regulated by Rho, not Rab, family GTPases.
The identiﬁcation of fascin as a Rab35 effector provides an
explanation for some of Rab35’s effects in actin dynamics, resulting
in ﬁlopodia formation and neurite extension. Modulation of actin
dynamics is an activity conventionally associated with Rho GTPas-
es rather than Rabs, but clearly there is a good degree of crosstalk
that occurs between the two classes of regulators [48]. Rab35’s
ability to activate Cdc42 is indicative of its inﬂuence on the regula-
tors of the latter. It should be noted that fascin is also regulated by
Rac activity [49], and could serve as an common downstream
mediator molecule for regulatory crosstalks between Rab35 and
Rac. Furthermore, Rab11-FIP3 is known to regulate Rac1-depen-
dent actin cytoskeleton dynamics, and modulates the formation
and rufﬂing of lamellipodia [50]. Several Rabs, including Rab11,
are known to engage the various isoforms of myosin V, an actin-based motor protein [51] in their trafﬁcking functions. Whether
Rab35 could also act likewise remains to be determined.6. Potential pathophysiological roles of Rab35
Other than developmental and physiological role of Rab35, its
pathological roles may also emerge in the near future. Rabs per-
forming recycling functions, particularly Rab25, have been exten-
sively implicated in human cancers [52,53], promoting cancer
cell migration and invasion through integrin recycling [54]. The
Rab coupling protein (RCP), which is an interacting partner of
Rab11 and Rab25, has likewise been implicated in oncogenesis
[55], functioning through coordination of integrin and epidermal
growth factor receptor (EGFR) recycling [56]. Rab35’s role in endo-
cytic recycling suggests that dysregulation of its levels, either
through gene ampliﬁcation or deletion, could speculatively perturb
the cell surface expression of integrins and other cell adhesion
molecules, particularly in cellular migration fronts. Interestingly,
Rab35 is the most highly upregulated small GTPase when andro-
gen responsive ovarian cancer cell is stimulated with dihydrotes-
tosterone [57]. Ninety-ﬁve percent of samples in the Newcastle
ovarian cancer tissue microarray (TMA) [58] is positive for
Rab35, although the staining showed no signiﬁcant correlation
with cancer staging and survival.
The newly discovered Rab35 effector, fascin, has also been
extensively implicated in a variety of human cancers (including
ovarian, prostate, liver and colon cancers). Its upregulation in a vari-
ety of human carcinomas, as well as its functional potential as a dri-
ver of oncogenic activities, has led to proposals of its potential as a
biomarker or therapeutic target [33]. It is again conceivable that
Table 1
Known interacting partners of Rab35 (see text).
Rab35 interacting partner Role Functional remarks
Nucleophosmin-anaplastic
lymphoma kinase (NPM-ALK)
[15]
Oncogene that participates in several key signaling pathways (e.g. PI3-K pathway)
and mediates interaction with certain signaling molecules (e.g. PLCc)
Overexpression of NPM-ALK found in
anaplastic large-cell lymphoma (ALCL)
p53-Related protein kinase
(PRPK) [16]
Binds and phosphorylates p53 at Ser 15 Possible role in oncogenesis/tumor
suppression
EBP50-PDZ interactor of 64k C
(EPI64C) [19]
GTPase-activating protein T-cell receptor exocytic function
RME-4 [18] Guanine nucleotide exchange factor (GEF) harboring a DENN domain C. elegans oocyte yolk protein receptor
recycling
Fascin [21] Effector of Rab35, an actin bundling protein Modulation of actin dynamics
C.E.L. Chua et al. / FEBS Letters 584 (2010) 1–6 5dysregulation of Rab35 levels could lead to untimely and undesir-
able activities of fascin that could inﬂuence cellular actin dynamics
associated with the oncogenic phenotype.7. Epilogue
Rab35 is a regulatory molecule with a dual capacity of regulat-
ing endocytic recycling and modulation of actin dynamics, and has
yet undeﬁned, but potentially essential roles in development and
diseases. As the list of its regulators and effectors (summarized
in Table 1) expand, and its connection with processes mediated
by Rab11 and Rho family GTPases are better understood, the mol-
ecule could turn out to be an important research handle and even a
clinically exploitable component of cellular physiology.
References
[1] Colicelli, J. (2004) Human RAS superfamily proteins and related GTPases. Sci.
STKE 2004, RE13.
[2] Gabe Lee, M.T., Mishra, A. and Lambright, D.G. (2009) Structural
mechanisms for regulation of membrane trafﬁc by Rab GTPases. Trafﬁc
10, 1377–1389.
[3] Stenmark, H. (2009) Rab GTPases as coordinators of vesicle trafﬁc. Nat. Rev.
Mol. Cell Biol. 10, 513–525.
[4] Sztul, E. and Lupashin, V. (2006) Role of tethering factors in secretory
membrane trafﬁc. Am. J. Physiol. Cell Physiol. 290, C11–C26.
[5] Hammer, J.A. and Wu, X.S. (2002) Rabs grab motors: deﬁning the connections
between Rab GTPases and motor proteins. Curr. Opin. Cell Biol. 14, 69–75.
[6] Bos, J.L., Rehmann, H. and Wittinghofer, A. (2007) GEFs and GAPs: critical
elements in the control of small G proteins. Cell 129, 865–877.
[7] Goody, R.S., Rak, A. and Alexandrov, K. (2005) The structural and mechanistic
basis for recycling of Rab proteins between membrane compartments. Cell
Mol. Life Sci. 62, 1657–1670.
[8] Seabra, M.C. andWasmeier, C. (2004) Controlling the location and activation of
Rab GTPases. Curr. Opin. Cell Biol. 16, 451–457.
[9] Zerial, M. and McBride, H. (2001) Rab proteins as membrane organizers. Nat.
Rev. Mol. Cell Biol. 2, 107–117.
[10] Nottingham, R.M. and Pfeffer, S.R. (2009) Deﬁning the boundaries: Rab GEFs
and GAPs. Proc. Natl. Acad. Sci. USA 106, 14185–14186.
[11] Rivera-Molina, F.E. and Novick, P.J. (2009) A Rab GAP cascade deﬁnes the
boundary between two Rab GTPases on the secretory pathway. Proc. Natl.
Acad. Sci. USA 106, 14408–14413.
[12] Zhu, A.X., Zhao, Y. and Flier, J.S. (1994) Molecular cloning of two small GTP-
binding proteins from human skeletal muscle. Biochem. Biophys. Res.
Commun. 205, 1875–1882.
[13] Bock, J.B., Matern, H.T., Peden, A.A. and Scheller, R.H. (2001) A genomic
perspective on membrane compartment organization. Nature 409, 839–
841.
[14] Pereira-Leal, J.B. and Seabra, M.C. (2001) Evolution of the Rab family of small
GTP-binding proteins. J. Mol. Biol. 313, 889–901.
[15] Crockett, D.K., Lin, Z., Elenitoba-Johnson, K.S.J. and Lim, M.S. (2004)
Identiﬁcation of NPM-ALK interacting proteins by tandem mass
spectrometry. Oncogene 23, 2617–2629.
[16] Abe, Y., Takeuchi, T., Imai, Y., Murase, R., Kamei, Y., Fujibuchi, T., Matsumoto,
S., Ueda, N., Ogasawara, M., Shigemoto, K. and Kito, K. (2006) A Small Ras-like
protein Ray/Rab1c modulates the p53-regulating activity of PRPK. Biochem.
Biophys. Res. Commun. 344, 377–385.
[17] Kouranti, I., Sachse, M., Arouche, N., Goud, B. and Echard, A. (2006) Rab35
regulates an endocytic recycling pathway essential for the terminal steps of
cytokinesis. Curr. Biol. 16, 1719–1725.[18] Sato, M., Sato, K., Liou, W., Pant, S., Harada, A. and Grant, B.D. (2008)
Regulation of endocytic recycling by C. elegans Rab35 and its regulator RME-4,
a coated-pit protein. EMBO J. 27, 1183–1196.
[19] Patino-Lopez, G., Dong, X., Ben-Aissa, K., Bernot, K.M., Itoh, T., Fukuda, M.,
Kruhlak, M.J., Samelson, L.E. and Shaw, S. (2008) Rab35 and its GAP EPI64C in T
cells regulate receptor recycling and immunological synapse formation. J. Biol.
Chem. 283, 18323–18330.
[20] Chevallier, J., Koop, C., Srivastava, A., Petrie, R.J., Lamarche-Vane, N. and
Presley, J.F. (2009) Rab35 regulates neurite outgrowth and cell shape. FEBS
Lett. 583, 1096–1101.
[21] Zhang, J., Fonovic, M., Suyama, K., Bogyo, M. and Scott, M.P. (2009) Rab35
controls actin bundling by recruiting fascin as an effector protein. Science 325,
1250–1254.
[22] Montagnac, G., Echard, A. and Chavrier, P. (2008) Endocytic trafﬁc in animal
cell cytokinesis. Curr. Opin. Cell Biol. 20, 454–461.
[23] Prekeris, R. and Gould, G.W. (2008) Breaking up is hard to do – membrane
trafﬁc in cytokinesis. J. Cell Sci. 121, 1569–1576.
[24] Yu, X., Prekeris, R. and Gould, G.W. (2007) Role of endosomal Rab GTPases in
cytokinesis. Eur. J. Cell Biol. 86, 25–35.
[25] Yuseff, M.I., Lankar, D. and Lennon-Duménil, A.M. (2009) Dynamics of
membrane trafﬁcking downstream of B and T cell receptor engagement:
impact on immune synapses. Trafﬁc 10, 629–636.
[26] Walseng, E., Bakke, O. and Roche, P.A. (2008) Major histocompatibility
complex class II-peptide complexes internalize using a clathrin- and
dynamin-independent endocytosis pathway. J. Biol. Chem. 283, 14717–14727.
[27] Levivier, E., Goud, B., Souchet, M., Calmels, T.P., Mornon, J.P. and
Callebaut, I. (2001) UDENN, DENN, and dDENN: indissociable domains
in Rab and MAP kinases signaling pathways. Biochem. Biophys. Res.
Commun. 287, 688–695.
[28] Miyoshi, J. and Takai, Y. (2004) Dual role of DENN/MADD (Rab3GEP) in
neurotransmission and neuroprotection. Trends Mol. Med. 10, 476–480.
[29] Miserey-Lenkei, S., Waharte, F., Boulet, A., Cuif, M.H., Tenza, D., El Marjou, A.,
Raposo, G., Salamero, J., Héliot, L., Goud, B. and Monier, S. (2007) Rab6-
interacting protein 1 links Rab6 and Rab11 function. Trafﬁc 8, 1385–1403.
[30] Jaffe, A.B. and Hall, A. (2005) Rho GTPases: biochemistry and biology. Annu.
Rev. Cell Dev. Biol. 21, 247–269.
[31] Kureishy, N., Sapountzi, V., Prag, S., Anilkumar, N. and Adams, J.C. (2002)
Fascins, and their roles in cell structure and function. Bioessays 24, 350–361.
[32] Adams, J.C. (2004) Roles of fascin in cell adhesion and motility. Curr. Opin. Cell
Biol. 16, 590–596.
[33] Hashimoto, Y., Skacel, M. and Adams, J.C. (2005) Roles of fascin in human
carcinoma motility and signaling: prospects for a novel biomarker? Int. J.
Biochem. Cell Biol. 37, 1787–1804.
[34] Van Ijzendoorn (2006) Recycling endosomes. J. Cell Sci. 119, 1679–1681.
[35] Jing, J. and Prekeris, R. (2009) Polarized endocytic transport: the roles of Rab11
and Rab11-FIPs in regulating cell polarity. Histol. Histopathol. 24, 1171–1180.
[36] Hoekstra, D., Tyteca, D. and van IJzendoorn, S.C.D. (2004) The subapical
compartment: a trafﬁc center in membrane polarity development. J. Cell Sci.
117, 2183–2192.
[37] Wang, X., Kumar, R., Navarre, J., Casanova, J.E. and Goldenring, J.R. (2000)
Regulation of vesicle trafﬁcking in madin-darby canine kidney cells by Rab11a
and Rab25. J. Biol. Chem. 275, 29138–29146.
[38] Ng, E.L. and Tang, B.L. (2008) Rab GTPases and their roles in brain neurons and
glia. Brain Res. Rev. 58, 236–246.
[39] Giansanti, M.G., Belloni, G. and Gatti, M. (2007) Rab11 is required for
membrane trafﬁcking and actomyosin ring constriction in meiotic
cytokinesis of Drosophila males. Mol. Biol. Cell 18, 5034–5047.
[40] Simon, G.C. and Prekeris, R. (2008) Mechanisms regulating targeting of
recycling endosomes to the cleavage furrow during cytokinesis. Biochem. Soc.
Trans. 36, 391–394.
[41] Cao, J., Albertson, R., Riggs, B., Field, C.M. and Sullivan, W. (2008) Nuf, a Rab11
effector, maintains cytokinetic furrow integrity by promoting local actin
polymerization. J. Cell Biol. 182, 301–313.
[42] Shirane, M. and Nakayama, K.I. (2006) Protrudin induces neurite formation by
directional membrane trafﬁcking. Science 314, 818–821.
6 C.E.L. Chua et al. / FEBS Letters 584 (2010) 1–6[43] Wu, S., Mehta, S.Q., Pichaud, F., Bellen, H.J. and Quiocho, F.A. (2005) Sec15
interacts with Rab11 via a novel domain and affects Rab11 localization in vivo.
Nat. Struct. Mol. Biol. 12, 879–885.
[44] Khvotchev, M.V., Ren, M., Takamori, S., Jahn, R. and Südhof, T.C. (2003)
Divergent functions of neuronal Rab11b in Ca2+-regulated versus constitutive
exocytosis. J. Neurosci. 23, 10531–10539.
[45] Bhuin, T. and Roy, J.K. (2009) Rab11 is required for embryonic nervous system
development in Drosophila. Cell Tissue Res. 335, 349–356.
[46] Gorska, M.M., Liang, Q., Karim, Z. and Alam, R. (2009) Uncoordinated 119
protein controls trafﬁcking of Lck via the Rab11 endosome and is critical for
immunological synapse formation. J. Immunol. 183, 1675–1684.
[47] de Renzis, S., Sönnichsen, B. and Zerial, M. (2002) Divalent Rab effectors
regulate the sub-compartmental organization and sorting of early endosomes.
Nat. Cell Biol. 4, 124–133.
[48] Qualmann, B. and Kessels, M.M. (2002) Endocytosis and the cytoskeleton. Int.
Rev. Cytol. 220, 93–144.
[49] Parsons, M. and Adams, J.C. (2008) Rac regulates the interaction of fascin with
protein kinase C in cell migration. J. Cell Sci. 121, 2805–2813.
[50] Jing, J., Tarbutton, E., Wilson, G. and Prekeris, R. (2009) Rab11-FIP3 is a Rab11-
binding protein that regulates breast cancer cell motility by modulating the
actin cytoskeleton. Eur. J. Cell Biol. 88, 325–341.
[51] Seabra, M.C. and Coudrier, E. (2004) Rab GTPases and myosin motors in
organelle motility. Trafﬁc 5, 393–399.
[52] Agarwal, R., Jurisica, I., Mills, G.B. and Cheng, K.W. (2009) The emerging role of
the RAB25 small GTPase in cancer. Trafﬁc 10, 1561–1568.[53] Cheng, K.W., Lahad, J.P., Kuo, W.L., Lapuk, A., Yamada, K., Auersperg, N., Liu, J.,
Smith-McCune, K., Lu, K.H., Fishman, D., Gray, J.W. and Mills, G.B. (2004) The
RAB25 small GTPase determines aggressiveness of ovarian and breast cancers.
Nat. Med. 10, 1251–1256.
[54] Caswell, P.T., Spence, H.J., Parsons, M., White, D.P., Clark, K., Cheng, K.W.,
Mills, G.B., Humphries, M.J., Messent, A.J., Anderson, K.I., McCaffrey, M.W.,
Ozanne, B.W. and Norman, J.C. (2007) Rab25 associates with alpha5beta1
integrin to promote invasive migration in 3D microenvironments. Dev. Cell
13, 496–510.
[55] Zhang, J., Liu, X., Datta, A., Govindarajan, K., Tam, W.L., Han, J., George, J., Wong,
C., Ramnarayanan, K., Phua, T.Y., Leong, W.Y., Chan, Y.S., Palanisamy, N., Liu,
E.T.B., Karuturi, K.M., Lim, B. and Miller, L.D. (2009) RCP is a human breast
cancer-promoting gene with Ras-activating function. J. Clin. Invest. 119,
2171–2183.
[56] Caswell, P.T., Chan, M., Lindsay, A.J., McCaffrey, M.W., Boettiger, D. and
Norman, J.C. (2008) Rab-coupling protein coordinates recycling of
alpha5beta1 integrin and EGFR1 to promote cell migration in 3D
microenvironments. J. Cell Biol. 183, 143–155.
[57] Sheach, L.A., Adeney, E.M., Kucukmetin, A., Wilkinson, S.J., Fisher, A.D., Elattar,
A., Robson, C.N. and Edmondson, R.J. (2009) Androgen-related expression of G-
proteins in ovarian cancer. Br. J. Cancer 101, 498–503.
[58] Wilkinson, S.J., Kucukmetin, A., Cross, P., Darby, S., Gnanapragasam, V.J.,
Calvert, A.H., Robson, C.N. and Edmondson, R.J. (2008) Expression of
gonadotrophin releasing hormone receptor I is a favorable prognostic factor
in epithelial ovarian cancer. Hum. Pathol. 39, 1197–1204.
